Safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) in homozygous MDR1-mutant collie dogs.

Riggs KL, Wang X, Wiseman S

Open source

DOI
10.1186/s13071-025-06795-y
Published
2025 Apr 23
Container
Parasites & vectors
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13071-025-06795-y,
  title = {Safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) in homozygous MDR1-mutant collie dogs.},
  author = {Riggs KL and Wang X and Wiseman S},
  year = {2025},
  journal = {Parasites \& vectors},
  doi = {10.1186/s13071-025-06795-y},
  url = {https://doi.org/10.1186/s13071-025-06795-y}
}

RIS

TY  - JOUR
TI  - Safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) in homozygous MDR1-mutant collie dogs.
AU  - Riggs KL
AU  - Wang X
AU  - Wiseman S
PY  - 2025
JO  - Parasites & vectors
DO  - 10.1186/s13071-025-06795-y
UR  - https://doi.org/10.1186/s13071-025-06795-y
ER  - 

APA

KL, R., X, W., & S, W. (2025). Safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) in homozygous MDR1-mutant collie dogs.. Parasites & vectors. https://doi.org/10.1186/s13071-025-06795-y

Source records